Reactive oxygen species have been described to modulate proteins within the cell, a process called redox regulation. However, the importance of compartment-specific redox regulation has been neglected for a long time. In the early 1980s and 1990s, many in vitro studies introduced the possibility that nuclear redox signaling exists. However, the functional relevance for that has been greatly disregarded. Recently, it has become evident that nuclear redox signaling is indeed one important signaling mechanism regulating a variety of cellular functions. Transcription factors, and even kinases and phosphatases, have been described to be redox regulated in the nucleus. This review describes several of these proteins in closer detail and explains their functions resulting from nuclear localization and redox regulation. Moreover, the redox state of the nucleus and several important nuclear redox regulators [Thioredoxin-1 (Trx-1), Glutaredoxins (Grxs), Peroxiredoxins (Prxs), and APEX nuclease (multifunctional DNA-repair enzyme) 1 (APEX1)] are introduced more precisely, and their necessity for regulation of transcription factors is emphasized. Antioxid. Redox Signal. 12, 713–742.
AbateC, PatelL, RauscherFJ3rd, CurranT. Redox regulation of fos and jun DNA-binding activity in vitro. Science, 249:1157–1161. 1990.
2.
AdachiM, SekiyaM, MiyachiT, MatsunoK, HinodaY, ImaiK, YachiA. Molecular cloning of a novel protein-tyrosine phosphatase SH-PTP3 with sequence similarity to the src-homology region 2. FEBS Lett, 314:335–339. 1992.
3.
AdachiT, PimentelDR, HeibeckT, HouX, LeeYJ, JiangB, IdoY, CohenRA. S-Glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem, 279:29857–29862. 2004.
4.
AhmadS, BanvilleD, ZhaoZ, FischerEH, ShenSH. A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. Proc Natl Acad Sci U S A, 90:2197–2201. 1993.
5.
AkamatsuY, OhnoT, HirotaK, KagoshimaH, YodoiJ, ShigesadaK. Redox regulation of the DNA binding activity in transcription factor PEBP2: the roles of two conserved cysteine residues. J Biol Chem, 272:14497–14500. 1997.
6.
AmmendolaR, MesuracaM, RussoT, CiminoF. Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues. J Biol Chem, 267:17944–17948. 1992.
7.
AmmendolaR, MesuracaM, RussoT, CiminoF. The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem, 225:483–489. 1994.
8.
AndoK, HiraoS, KabeY, OguraY, SatoI, YamaguchiY, WadaT, HandaH. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res, 36:4327–4336. 2008.
9.
AndricopuloAD, AkoachereMB, KroghR, NickelC, McLeishMJ, KenyonGL, ArscottLD, Williams CHJr, Davioud-CharvetE, BeckerK. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Bioorg Med Chem Lett, 16:2283–2292. 2006.
10.
AokiN, MatsudaT. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol Endocrinol, 16:58–69. 2002.
11.
ArnoneMI, ZanniniM, Di LauroR. The DNA binding activity and the dimerization ability of the thyroid transcription factor I are redox regulated. J Biol Chem, 270:12048–12055. 1995.
12.
AshleyRH. Challenging accepted ion channel biology: p64 and the CLIC family of putative intracellular anion channel proteins [Review]Mol Membr Biol, 20:1–11. 2003.
13.
BandyopadhyayS, GronostajskiRM. Identification of a conserved oxidation-sensitive cysteine residue in the NFI family of DNA-binding proteins. J Biol Chem, 269:29949–29955. 1994.
14.
BandyopadhyayS, StarkeDW, MieyalJJ, GronostajskiRM. Thioltransferase (glutaredoxin) reactivates the DNA-binding activity of oxidation-inactivated nuclear factor I. J Biol Chem, 273:392–397. 1998.
15.
BanmeyerI, MarchandC, VerhaegheC, VucicB, ReesJF, KnoopsB. Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radic Biol Med, 36:65–77. 2004.
16.
BannisterAJ, CookA, KouzaridesT. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene, 6:1243–1250. 1991.
17.
BarlowCA, KitiphongspattanaK, SiddiquiN, RoeMW, MossmanBT, LounsburyKM. Protein kinase A-mediated CREB phosphorylation is an oxidant-induced survival pathway in alveolar type II cells. Apoptosis, 13:681–692. 2008.
18.
BarlowCA, ShuklaA, MossmanBT, LounsburyKM. Oxidant-mediated cAMP response element binding protein activation: calcium regulation and role in apoptosis of lung epithelial cells. Am J Respir Cell Mol Biol, 34:7–14. 2006.
19.
BarrettWC, DeGnoreJP, KonigS, FalesHM, KengYF, ZhangZY, YimMB, ChockPB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry, 38:6699–6705. 1999.
20.
BelichMP, SalmeronA, JohnstonLH, LeySC. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Nature, 397:363–368. 1999.
21.
BenbrookDM, JonesNC. Heterodimer formation between CREB and JUN proteins. Oncogene, 5:295–302. 1990.
22.
BhartiA, KraeftSK, GounderM, PandeyP, JinS, YuanZM, Lees-MillerSP, WeichselbaumR, WeaverD, ChenLB, KufeD, KharbandaS. Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol, 18:6719–6728. 1998.
23.
BjörkblomB, Ouml;stmanN, HongistoV, KomarovskiV, FilenJJ, NymanTA, KallunkiT, CourtneyMJ, CoffeyET. Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J Neurosci, 25:6350–6361. 2005.
24.
BjörkblomB, VainioJC, HongistoV, HerdegenT, CourtneyMJ, CoffeyET. All JNKs can kill, but nuclear localization is critical for neuronal death. J Biol Chem, 283:19704–19713. 2008.
25.
BlassM, KronfeldI, KazimirskyG, BlumbergPM, BrodieC. Tyrosine phosphorylation of protein kinase Cdelta is essential for its apoptotic effect in response to etoposide. Mol Cell Biol, 22:182–195. 2002.
26.
BloomD, DhakshinamoorthyS, JaiswalAK. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene, 21:2191–2200. 2002.
27.
BloomfieldKL, OsborneSA, KennedyDD, ClarkeFM, TonissenKF. Thioredoxin-mediated redox control of the transcription factor Sp1 and regulation of the thioredoxin gene promoter. Gene, 319:107–116. 2003.
28.
BourdonJC. p53 and its isoforms in cancer. Br J Cancer, 97:277–282. 2007.
29.
BreitschopfK, ZeiherAM, DimmelerS. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett, 493:21–25. 2001.
30.
Camper-KirbyD, WelchS, WalkerA, ShiraishiI, SetchellKD, SchaeferE, KajsturaJ, AnversaP, SussmanMA. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res, 88:1020–1027. 2001.
31.
CarpenterG. Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J Cell Biol, 146:697–702. 1999.
32.
ChandrasekaranV, TaylorEW. Molecular modeling of the oxidized form of nuclear factor-kappa B suggests a mechanism for redox regulation of DNA binding and transcriptional activation. J Mol Graph Model, 26:861–867. 2008.
33.
ChenCY, WillardD, RudolphJ. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines. Biochemistry, 48:1399–1409. 2009.
34.
ChenH, LiX, EpsteinPN. MnSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity. Diabetes, 54:1437–1446. 2005.
35.
ChinenovY, KerppolaTK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene, 20:2438–2452. 2001.
ChughtaiN, SchimchowitschS, LebrunJJ, AliS. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells. J Biol Chem, 277:31107–31114. 2002.
38.
ClaiborneA, YehJI, MallettTC, LubaJ Crane EJ 3rd, CharrierV, ParsonageD. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry, 38:15407–15416. 1999.
39.
ConourJE, GrahamWV, GaskinsHR. A combined in vitro/bioinformatic investigation of redox regulatory mechanisms governing cell cycle progression. Physiol Genom, 18:196–205. 2004.
40.
Darnell JEJr, KerrIM, StarkGR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264:1415–1421. 1994.
41.
DavisRJ. Signal transduction by the JNK group of MAP kinases. Cell, 103:239–252. 2000.
42.
de JongRN, van der VlietPC. Mechanism of DNA replication in eukaryotic cells: cellular host factors stimulating adenovirus DNA replication. Gene, 236:1–12. 1999.
43.
DelMaestro R, McDonaldW. Subcellular localization of superoxide dismutases, glutathione peroxidase and catalase in developing rat cerebral cortex. Mech Ageing Dev, 48:15–31. 1989.
44.
DelphinC, CahenP, LawrenceJJ, BaudierJ. Characterization of baculovirus recombinant wild-type p53: dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur J Biochem, 223:683–692. 1994.
45.
DenuJM, TannerKG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry, 37:5633–5642. 1998.
46.
DeVriesTA, NevilleMC, ReylandME. Nuclear import of PKCdelta is required for apoptosis: identification of a novel nuclear import sequence. EMBO J, 21:6050–6060. 2002.
47.
Dinkova-KostovaAT, HoltzclawWD, ColeRN, ItohK, WakabayashiN, KatohY, YamamotoM, TalalayP. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A, 99:11908–11913. 2002.
48.
DunphyWG, KumagaiA. The cdc25 protein contains an intrinsic phosphatase activity. Cell, 67:189–196. 1991.
49.
EgloffMP, JohnsonDF, MoorheadG, CohenPT, CohenP, BarfordD. Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J, 16:1876–1887. 1997.
50.
EklundH, CambillauC, SjobergBM, HolmgrenA, JornvallH, HoogJO, BrandenCI. Conformational and functional similarities between glutaredoxin and thioredoxins. EMBO J, 3:1443–1449. 1984.
51.
EmaM, HirotaK, MimuraJ, AbeH, YodoiJ, SogawaK, PoellingerL, Fujii-KuriyamaY. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J, 18:1905–1914. 1999.
52.
EspositoF, CuccovilloF, MorraF, RussoT, CiminoF. DNA binding activity of the glucocorticoid receptor is sensitive to redox changes in intact cells. Biochim Biophys Acta, 1260:308–314. 1995.
53.
FanM, ChambersTC. Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy. Drug Resist Update, 4:253–267. 2001.
54.
FengGS, HuiCC, PawsonT. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science, 259:1607–1611. 1993.
55.
Freeman RMJr, PlutzkyJ, NeelBG. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci U S A, 89:11239–11243. 1992.
56.
FuW, BegleyJG, KillenMW, MattsonMP. Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem, 274:7264–7271. 1999.
57.
GaiddonC, MoorthyNC, PrivesC. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J, 18:5609–5621. 1999.
58.
GalangCK, HauserCA. Cooperative DNA binding of the human HoxB5 (Hox-2.1) protein is under redox regulation in vitro. Mol Cell Biol, 13:4609–4617. 1993.
59.
GeorgiadisMM, LuoM, GaurRK, DelaplaneS, LiX, KelleyMR. Evolution of the redox function in mammalian apurinic/apyrimidinic endonuclease. Mutat Res, 643:54–63. 2008.
60.
GhayurT, HuguninM, TalanianRV, RatnofskyS, QuinlanC, EmotoY, PandeyP, DattaR, HuangY, KharbandaS, AllenH, KamenR, WongW, KufeD. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med, 184:2399–2404. 1996.
61.
GieblerHA, LoringJE, vanOrden K, ColginMA, GarrusJE, EscuderoKW, BrauweilerA, NyborgJK. Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation. Mol Cell Biol, 17:5156–5164. 1997.
62.
GladyshevVN, LiuA, NovoselovSV, KrysanK, SunQA, KryukovVM, KryukovGV, LouMF. Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. J Biol Chem, 276:30374–30380. 2001.
63.
GoldkornT, BalabanN, MatsukumaK, CheaV, GouldR, LastJ, ChanC, ChavezC. EGF-receptor phosphorylation and signaling are targeted by H2O2 redox stress. Am J Respir Cell Mol Biol, 19:786–798. 1998.
64.
GorenI, TavorE, GoldblumA, HonigmanA. Two cysteine residues in the DNA-binding domain of CREB control binding to CRE and CREB-mediated gene expression. J Mol Biol, 313:695–709. 2001.
65.
GronostajskiRM. Roles of the NFI/CTF gene family in transcription and development. Gene, 249:31–45. 2000.
GuehmannS, VorbrueggenG, KalkbrennerF, MoellingK. Reduction of a conserved Cys is essential for Myb DNA-binding. Nucleic Acids Res, 20:2279–2286. 1992.
68.
HaendelerJ, HoffmannJ, BrandesRP, ZeiherAM, DimmelerS. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol, 23:4598–4610. 2003.
69.
HaendelerJ, HoffmannJ, DiehlJF, VasaM, SpyridopoulosI, ZeiherAM, DimmelerS. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res, 94:768–775. 2004.
70.
HaendelerJ, HoffmannJ, RahmanS, ZeiherAM, DimmelerS. Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation. FEBS Lett, 536:180–186. 2003.
71.
HagiwaraM, BrindleP, HarootunianA, ArmstrongR, RivierJ, ValeW, TsienR, MontminyMR. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol, 13:4852–4859. 1993.
72.
HaiT, CurranT. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A, 88:3720–3724. 1991.
73.
HainautP, MilnerJ. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res, 53:4469–4473. 1993.
74.
HansenJM, GongSG, PhilbertM, HarrisC. Misregulation of gene expression in the redox-sensitive NF-kappab-dependent limb outgrowth pathway by thalidomide. Dev Dyn, 225:186–194. 2002.
HansenJM, WatsonWH, JonesDP. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci, 82:308–317. 2004.
77.
HansonS, KimE, DeppertW. Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization. Oncogene, 24:1641–1647. 2005.
78.
HayashiS, Hajiro-NakanishiK, MakinoY, EguchiH, YodoiJ, TanakaH. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res, 25:4035–4040. 1997.
79.
HirotaK, MatsuiM, IwataS, NishiyamaA, MoriK, YodoiJ. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A, 94:3633–3638. 1997.
80.
HirotaK, MatsuiM, MurataM, TakashimaY, ChengFS, ItohT, FukudaK, YodoiJ. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem Biophys Res Commun, 274:177–182. 2000.
81.
HirotaK, MurataM, SachiY, NakamuraH, TakeuchiJ, MoriK, YodoiJ. Distinct roles of thioredoxin in the cytoplasm and in the nucleus: a two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem, 274:27891–27897. 1999.
82.
HofP, PluskeyS, Dhe-PaganonS, EckMJ, ShoelsonSE. Crystal structure of the tyrosine phosphatase SHP-2. Cell, 92:441–450. 1998.
83.
HohJ, JinS, ParradoT, EdingtonJ, LevineAJ, OttJ. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci U S A, 99:8467–8472. 2002.
84.
HollsteinM, SidranskyD, VogelsteinB, HarrisCC. p53 mutations in human cancers. Science, 253:49–53. 1991.
85.
HolmgrenA. Thioredoxin 6: the amino acid sequence of the protein from Escherichia coli B. Eur J Biochem, 6:475–484. 1968.
86.
HolmgrenA. Glutathione-dependent synthesis of deoxyribonucleotides: purification and characterization of glutaredoxin from Escherichia coli. J Biol Chem, 254:3664–3671. 1979.
87.
HolmgrenA. Thioredoxin. Annu Rev Biochem, 54:237–271. 1985.
88.
HolmgrenA, SoderbergBO, EklundH, BrandenCI. Three-dimensional structure of Escherichia coli thioredoxin-S2 to 2.8 A resolution. Proc Natl Acad Sci U S A, 72:2305–2309. 1975.
89.
HoltSE, AisnerDL, BaurJ, TesmerVM, DyM, OuelletteM, TragerJB, MorinGB, ToftDO, ShayJW, WrightWE, WhiteMA. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev, 13:817–826. 1999.
90.
HuangLE, AranyZ, LivingstonDM, BunnHF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem, 271:32253–32259. 1996.
91.
HuangRP, AdamsonED. Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism. DNA Cell Biol, 12:265–273. 1993.
92.
HughesMN. Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. Biochim Biophys Acta, 1411:263–272. 1999.
93.
HutchisonKA, MaticG, MeshinchiS, BresnickEH, PrattWB. Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor. J Biol Chem, 266:10505–10509. 1991.
94.
IsakovN, WitteS, AltmanA. PICOT-HD: a highly conserved protein domain that is often associated with thioredoxin and glutaredoxin modules. Trends Biochem Sci, 25:537–539. 2000.
JakobS, SchroederP, LukoszM, BuchnerN, SpyridopoulosI, AltschmiedJ, HaendelerJ. Nuclear protein tyrosine phosphatase shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase. J Biol Chem, 283:33155–33161. 2008.
97.
JayaramanL, MurthyKG, ZhuC, CurranT, XanthoudakisS, PrivesC. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev, 11:558–570. 1997.
98.
JohnsonGL, LapadatR. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 298:1911–1912. 2002.
99.
JohnsonLN, NobleME, OwenDJ. Active and inactive protein kinases: structural basis for regulation. Cell, 85:149–158. 1996.
KagoshimaH, AkamatsuY, ItoY, ShigesadaK. Functional dissection of the alpha and beta subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J Biol Chem, 271:33074–33082. 1996.
102.
KalininaEV, ChernovNN, SaprinAN. Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes. Biochemistry (Mosc), 73:1493–1510. 2008.
103.
KambeF, NomuraY, OkamotoT, SeoH. Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Mol Endocrinol, 10:801–812. 1996.
104.
KaneshiroK, TsutsumiS, TsujiS, ShirahigeK, AburataniH. An integrated map of p53-binding sites and histone modification in the human ENCODE regions. Genomics, 89:178–188. 2007.
105.
KangSS, KwonT, KwonDY, DoSI. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem, 274:13085–13090. 1999.
106.
KembleDJ, SunG. Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation. Proc Natl Acad Sci U S A, 106:5070–5075. 2009.
107.
KenslerTW, WakabayashiN, BiswalS. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol, 47:89–116. 2007.
108.
KhokhlatchevAV, CanagarajahB, WilsbacherJ, RobinsonM, AtkinsonM, GoldsmithE, CobbMH. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell, 93:605–615. 1998.
109.
KinnulaVL, LehtonenS, SormunenR, Kaarteenaho-WiikR, KangSW, RheeSG, SoiniY. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol, 196:316–323. 2002.
110.
KnoepfelL, SteinkuhlerC, CarriMT, RotilioG. Role of zinc-coordination and of the glutathione redox couple in the redox susceptibility of human transcription factor Sp1. Biochem Biophys Res Commun, 201:871–877. 1994.
111.
KugeS, TodaT, IizukaN, NomotoA. Crm1 (XpoI) dependent nuclear export of the budding yeast transcription factor yAP-1 is sensitive to oxidative stress. Genes Cells, 3:521–532. 1998.
112.
KumagaiA, DunphyWG. The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. Cell, 64:903–914. 1991.
113.
KwonJ, LeeSR, YangKS, AhnY, KimYJ, StadtmanER, RheeSG. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci U S A, 101:16419–16424. 2004.
114.
LamMH, MichellBJ, Fodero-TavolettiMT, KempBE, TonksNK, TiganisT. Cellular stress regulates the nucleocytoplasmic distribution of the protein-tyrosine phosphatase TCPTP. J Biol Chem, 276:37700–37707. 2001.
115.
LamaliceL, HouleF, JourdanG, HuotJ. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene, 23:434–445. 2004.
116.
LandoD, PongratzI, PoellingerL, WhitelawML. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J Biol Chem, 275:4618–4627. 2000.
117.
LaneDP. p53, guardian of the genome. Nature, 358:15–16. 1992.
118.
LaurentTC, MooreEC, ReichardP. Enzymatic synthesis of deoxyribonucleotides. IV, isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J Biol Chem, 239:3436–3444. 1964.
119.
LeeW, HaslingerA, KarinM, TjianR. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature, 325:368–372. 1987.
120.
LeslieNR, BennettD, LindsayYE, StewartH, GrayA, DownesCP. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J, 22:5501–5510. 2003.
121.
LiL, LorenzoPS, BogiK, BlumbergPM, YuspaSH. Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector. Mol Cell Biol, 19:8547–8558. 1999.
122.
LiangX, LuB, ScottGK, ChangCH, BaldwinMA, BenzCC. Oxidant stress impaired DNA-binding of estrogen receptor from human breast cancer. Mol Cell Endocrinol, 146:151–161. 1998.
LilligCH, HolmgrenA. Thioredoxin and related molecules: from biology to health and disease. Antioxid Redox Signal, 9:25–47. 2007.
125.
LinA, DiblingB. The true face of JNK activation in apoptosis. Aging Cell, 1:112–116. 2002.
126.
LindC, GerdesR, Schuppe-KoistinenI, CotgreaveIA. Studies on the mechanism of oxidative modification of human glyceraldehyde-3-phosphate dehydrogenase by glutathione: catalysis by glutaredoxin. Biochem Biophys Res Commun, 247:481–486. 1998.
127.
LiuH, NishitohH, IchijoH, KyriakisJM. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol, 20:2198–2208. 2000.
128.
LiuJ, LinA. Role of JNK activation in apoptosis: a double-edged sword. Cell Res, 15:36–42. 2005.
129.
LönnME, HudemannC, BerndtC, CherkasovV, CapaniF, HolmgrenA, LilligCH. Expression pattern of human glutaredoxin 2 isoforms: identification and characterization of two testis/cancer cell-specific isoforms. Antioxid Redox Signal, 10:547–557. 2008.
130.
LorenzenJA, DadabayCY, FischerEH. COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Biol, 131:631–643. 1995.
131.
LundbergM, JohanssonC, ChandraJ, EnokssonM, JacobssonG, LjungJ, JohanssonM, HolmgrenA. Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem, 276:26269–26275. 2001.
132.
LuoM, DelaplaneS, JiangA, ReedA, HeY, FishelM Nyland RL 2nd, BorchRF, QiaoX, GeorgiadisMM, KelleyMR. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal, 10:1853–1867. 2008.
133.
LysellJ, StjernholmVladic Y, CiarloN, HolmgrenA, SahlinL. Immunohistochemical determination of thioredoxin and glutaredoxin distribution in the human cervix, and possible relation to cervical ripening. Gynecol Endocrinol, 17:303–310. 2003.
134.
MakinoY, OkamotoK, YoshikawaN, AoshimaM, HirotaK, YodoiJ, UmesonoK, MakinoI, TanakaH. Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action: cross talk between endocrine control of stress response and cellular antioxidant defense system. J Clin Invest, 98:2469–2477. 1996.
135.
MakinoY, YoshikawaN, OkamotoK, HirotaK, YodoiJ, MakinoI, TanakaH. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J Biol Chem, 274:3182–3188. 1999.
136.
ManevichY, FeinsteinSI, FisherAB. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci U S A, 101:3780–3785. 2004.
137.
MarkovicJ, BorrasC, OrtegaA, SastreJ, VinaJ, PallardoFV. Glutathione is recruited into the nucleus in early phases of cell proliferation. J Biol Chem, 282:20416–20424. 2007.
138.
MarkovicJ, MoraNJ, BrosetaAM, GimenoA, de-la-ConcepcionN, VinaJ, PallardoFV. The depletion of nuclear glutathione impairs cell proliferation in 3t3 fibroblasts. PLoS One, 4:e6413. 2009.
139.
MartinJL. Thioredoxin: a fold for all reasons. Structure, 3:245–250. 1995.
140.
MatesJM, SeguraJA, AlonsoFJ, MarquezJ. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol, 82:273–299. 2008.
141.
MatthewsJR, BottingCH, PanicoM, MorrisHR, HayRT. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res, 24:2236–2242. 1996.
142.
MatthewsJR, WakasugiN, VirelizierJL, YodoiJ, HayRT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res, 20:3821–3830. 1992.
143.
MattilaE, AuvinenK, SalmiM, IvaskaJ. The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling. J Cell Sci, 121:3570–3580. 2008.
144.
MattsonMP, KlapperW. Emerging roles for telomerase in neuronal development and apoptosis. J Neurosci Res, 63:1–9. 2001.
145.
MayrB, MontminyM. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol, 2:599–609. 2001.
146.
McBrideAA, KlausnerRD, HowleyPM. Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro. Proc Natl Acad Sci U S A, 89:7531–7535. 1992.
147.
McEwanIJ. Nuclear receptors: one big family. Methods Mol Biol, 505:3–18. 2009.
148.
McMahonM, ItohK, YamamotoM, ChanasSA, HendersonCJ, McLellanLI, WolfCR, CavinC, HayesJD. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res, 61:3299–3307. 2001.
149.
MeisterA, AndersonME. Glutathione. Annu Rev Biochem, 52:711–760. 1983.
150.
MengTC, FukadaT, TonksNK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell, 9:387–399. 2002.
151.
MirkovicN, VoehringerDW, StoryMD, McConkeyDJ, McDonnellTJ, MeynRE. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene, 15:1461–1470. 1997.
152.
MonteiroG, HortaBB, PimentaDC, AugustoO, NettoLE. Reduction of 1-Cys peroxiredoxins by ascorbate changes the thiol-specific antioxidant paradigm, revealing another function of vitamin C. Proc Natl Acad Sci U S A, 104:4886–4891. 2007.
153.
MorelY, BaroukiR. The repression of nuclear factor I/CCAAT transcription factor (NFI/CTF) transactivating domain by oxidative stress is mediated by a critical cysteine (Cys-427)Biochem J, 348:235–240. 2000.
154.
MorelY, CoumoulX, NalpasA, BaroukiR. Nuclear factor I/CCAAT box transcription factor trans-activating domain is a negative sensor of cellular stress. Mol Pharmacol, 58:1239–1246. 2000.
155.
MyrsetAH, BostadA, JaminN, LirsacPN, TomaF, GabrielsenOS. DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein. EMBO J, 12:4625–4633. 1993.
156.
NakshatriH, Bhat-NakshatriP, CurrieRA. Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J Biol Chem, 271:28784–28791. 1996.
157.
NatoliG, De SantaF. Shaping alternative NF-kappaB-dependent gene expression programs: new clues to specificity. Cell Death Differ, 13:693–696. 2006.
158.
NguyenT, PickettCB, NioiP. The Nrf2-ARE signaling pathway and its activation by oxidative stress. J Biol Chem, 284:13291–13295. 2009.
159.
NguyenT, YangCS, PickettCB. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med, 37:433–441. 2004.
160.
NiggEA, BaeuerlePA, LuhrmannR. Nuclear import-export: in search of signals and mechanisms. Cell, 66:15–22. 1991.
161.
NolanGP, BaltimoreD. The inhibitory ankyrin and activator Rel proteins. Curr Opin Genet Dev, 2:211–220. 1992.
162.
NordbergJ, ArnerES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med, 31:1287–1312. 2001.
163.
NottA, WatsonPM, RobinsonJD, CrepaldiL, RiccioA. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature, 455:411–415. 2008.
164.
NovakA, GoyalN, GronostajskiRM. Four conserved cysteine residues are required for the DNA binding activity of nuclear factor I. J Biol Chem, 267:12986–12990. 1992.
165.
O'NeillE, KolchW. Conferring specificity on the ubiquitous Raf/MEK signalling pathway. Br J Cancer, 90:283–288. 2004.
166.
OhH, TaffetGE, YoukerKA, EntmanML, OverbeekPA, MichaelLH, SchneiderMD. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A, 98:10308–10313. 2001.
167.
OkamotoK, TanakaH, OgawaH, MakinoY, EguchiH, HayashiS, YoshikawaN, PoellingerL, UmesonoK, MakinoI. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem, 274:10363–10371. 1999.
168.
OkunoH, AkahoriA, SatoH, XanthoudakisS, CurranT, IbaH. Escape from redox regulation enhances the transforming activity of Fos. Oncogene, 8:695–701. 1993.
169.
OrdwayJM, EberhartD, CurranT. Cysteine 64 of Ref-1 is not essential for redox regulation of AP-1 DNA binding. Mol Cell Biol, 23:4257–4266. 2003.
170.
OsawaM, ItohS, OhtaS, HuangQ, BerkBC, MarmaroshNL, CheW, DingB, YanC, AbeJ. ERK1/2 associates with the c-Met-binding domain of growth factor receptor-bound protein 2 (Grb2)-associated binder-1 (Gab1): role in ERK1/2 and early growth response factor-1 (Egr-1) nuclear accumulation. J Biol Chem, 279:29691–29699. 2004.
171.
PaiHV, StarkeDW, LesnefskyEJ, HoppelCL, MieyalJJ. What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria?Antioxid Redox Signal, 9:2027–2033. 2007.
172.
PallardoFV, MarkovicJ, GarciaJL, VinaJ. Role of nuclear glutathione as a key regulator of cell proliferation. Mol Aspects Med, 30:77–85. 2009.
173.
PanS, BerkBC. Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway. Circ Res, 100:213–219. 2007.
174.
PaolilloM, FelicielloA, PorcelliniA, GarbiC, BifulcoM, SchinelliS, VentraC, StabileE, RicciardelliG, SchettiniG, AvvedimentoEV. The type and the localization of cAMP-dependent protein kinase regulate transmission of cAMP signals to the nucleus in cortical and cerebellar granule cells. J Biol Chem, 274:6546–6552. 1999.
175.
PapavassiliouAG. The CREB/ATF family of transcription factors: modulation by reversible phosphorylation. Anticancer Res, 14:1801–1805. 1994.
176.
ParkSW, HuqMD, HuX, WeiLN. Tyrosine nitration on p65: a novel mechanism to rapidly inactivate nuclear factor-kappaB. Mol Cell Proteomics, 4:300–309. 2005.
177.
ParksD, BolingerR, MannK. Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA. Nucleic Acids Res, 25:1289–1295. 1997.
178.
ParsonsSJ, ParsonsJT. Src family kinases, key regulators of signal transduction. Oncogene, 23:7906–7909. 2004.
179.
PengCY, GravesPR, ThomaRS, WuZ, ShawAS, Piwnica-WormsH. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277:1501–1505. 1997.
180.
PerssonC, SjoblomT, GroenA, KappertK, EngstromU, HellmanU, HeldinCH, denHertog J, OstmanA. Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci U S A, 101:1886–1891. 2004.
181.
Pineda-MolinaE, KlattP, VazquezJ, MarinaA, Garcia deLacoba M, Perez-SalaD, LamasS. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry, 40:14134–14142. 2001.
182.
QanungoS, StarkeDW, PaiHV, MieyalJJ, NieminenAL. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J Biol Chem, 282:18427–18436. 2007.
183.
QuanX, TsoulosP, KuritzkyA, ZhangR, StochajU. The carrier Msn5p/Kap142p promotes nuclear export of the hsp70 Ssa4p and relocates in response to stress. Mol Microbiol, 62:592–609. 2006.
184.
QuanX, YuJ, BusseyH, StochajU. The localization of nuclear exporters of the importin-beta family is regulated by Snf1 kinase, nutrient supply and stress. Biochim Biophys Acta, 1773:1052–1061. 2007.
185.
RainwaterR, ParksD, AndersonME, TegtmeyerP, MannK. Role of cysteine residues in regulation of p53 function. Mol Cell Biol, 15:3892–3903. 1995.
186.
Ramos-GomezM, KwakMK, DolanPM, ItohK, YamamotoM, TalalayP, KenslerTW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A, 98:3410–3415. 2001.
187.
RheeSG, ChaeHZ, KimK. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med, 38:1543–1552. 2005.
188.
RheeSG, KangSW, ChangTS, JeongW, KimK. Peroxiredoxin, a novel family of peroxidases. IUBMB Life, 52:35–41. 2001.
189.
RichardsJP, BächingerHP, GoodmanRH, BrennanRG. Analysis of the structural properties of cAMP-responsive element-binding protein (CREB) and phosphorylated CREB. J Biol Chem, 271:13716–13723. 1996.
190.
Rodriguez-ManzanequeMT, TamaritJ, BelliG, RosJ, HerreroE. Grx5 is a mitochondrial glutaredoxin required for the activity of iron/sulfur enzymes. Mol Biol Cell, 13:1109–1121. 2002.
191.
RogersLK, GuptaS, WeltySE, HansenTN, SmithCV. Nuclear and nucleolar glutathione reductase, peroxidase, and transferase activities in livers of male and female Fischer-344 rats. Toxicol Sci, 69:279–285. 2002.
192.
RudolphKL, ChangS, MillardM, Schreiber-AgusN, DePinhoRA. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science, 287:1253–1258. 2000.
193.
SafeS, AbdelrahimM. Sp transcription factor family and its role in cancer. Eur J Cancer, 41:2438–2448. 2005.
194.
SaitohM, NishitohH, FujiiM, TakedaK, TobiumeK, SawadaY, KawabataM, MiyazonoK, IchijoH. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J, 17:2596–2606. 1998.
195.
SanchezY, WongC, ThomaRS, RichmanR, WuZ, Piwnica-WormsH, ElledgeSJ. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science, 277:1497–1501. 1997.
196.
Sanchez-PerezI, MurguiaJR, PeronaR. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene, 16:533–540. 1998.
197.
Sassone-CorsiP. Transcription factors responsive to cAMP. Annu Rev Cell Dev Biol, 11:355–377. 1995.
SchäferD, Hamm-KunzelmannB, HermfisseU, BrandK. Differences in DNA-binding efficiency of Sp1 to aldolase and pyruvate kinase promoter correlate with altered redox states in resting and proliferating rat thymocytes. FEBS Lett, 391:35–38. 1996.
200.
SchaferFQ, BuettnerGR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med, 30:1191–1212. 2001.
201.
ScheidereitC. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene, 25:6685–6705. 2006.
202.
SchröderE, PontingCP. Evidence that peroxiredoxins are novel members of the thioredoxin fold superfamily. Protein Sci, 7:2465–2468. 1998.
203.
SchroederP, PoppR, WiegandB, AltschmiedJ, HaendelerJ. Nuclear redox-signaling is essential for apoptosis inhibition in endothelial cells: important role for nuclear thioredoxin-1. Arterioscler Thromb Vasc Biol, 27:2325–2331. 2007.
204.
SchulzePC, De KeulenaerGW, YoshiokaJ, KassikKA, LeeRT. Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res, 91:689–695. 2002.
205.
SemenzaGL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol, 15:551–578. 1999.
206.
SemenzaGL. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell, 107:1–3. 2001.
207.
SenR, BaltimoreD. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell, 47:921–928. 1986.
208.
SenR, BaltimoreD. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 46:705–716. 1986.
209.
ShenolikarS. Protein serine/threonine phosphatases: new avenues for cell regulation. Annu Rev Cell Biol, 10:55–86. 1994.
210.
ShigemoriK, IshizakiT, MatsukawaS, SakaiA, NakaiT, MiyaboS. Adenine nucleotides via activation of ATP-sensitive K + channels modulate hypoxic response in rat pulmonary artery. Am J Physiol, 270:L803–L809. 1996.
211.
ShiraishiI, MelendezJ, AhnY, SkavdahlM, MurphyE, WelchS, SchaeferE, WalshK, RosenzweigA, TorellaD, NurzynskaD, KajsturaJ, LeriA, AnversaP, SussmanMA. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res, 94:884–891. 2004.
212.
SilvaCM, CidlowskiJA. Direct evidence for intra- and intermolecular disulfide bond formation in the human glucocorticoid receptor: inhibition of DNA binding and identification of a new receptor-associated protein. J Biol Chem, 264:6638–6647. 1989.
213.
SmeenkL, van HeeringenSJ, KoeppelM, van DrielMA, BartelsSJ, AkkersRC, DenissovS, StunnenbergHG, LohrumM. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res, 36:3639–3654. 2008.
214.
SmithGC, JacksonSP. The DNA-dependent protein kinase. Genes Dev, 13:916–934. 1999.
215.
SobollS, GrundelS, HarrisJ, Kolb-BachofenV, KettererB, SiesH. The content of glutathione and glutathione S-transferases and the glutathione peroxidase activity in rat liver nuclei determined by a non-aqueous technique of cell fractionation. Biochem J, 311:889–894. 1995.
216.
SohnJ, RudolphJ. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry, 42:10060–10070. 2003.
217.
SoussiT, BeroudC. Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides. Hum Mutat, 21:192–200. 2003.
218.
StarovasnikMA, BlackwellTK, LaueTM, WeintraubH, KlevitRE. Folding topology of the disulfide-bonded dimeric DNA-binding domain of the myogenic determination factor MyoD. Biochemistry, 31:9891–9903. 1992.
219.
Stavreus-EversA, MasironiB, LandgrenBM, HolmgrenA, ErikssonH, SahlinL. Immunohistochemical localization of glutaredoxin and thioredoxin in human endometrium: a possible association with pinopodes. Mol Hum Reprod, 8:546–551. 2002.
220.
StellaL, PallottiniV, MorenoS, LeoniS, DeMaria F, TurellaP, FedericiG, FabriniR, DawoodKF, BelloML, PedersenJZ, RicciG. Electrostatic association of glutathione transferase to the nuclear membrane: evidence of an enzyme defense barrier at the nuclear envelope. J Biol Chem, 282:6372–6379. 2007.
221.
StubbsM, VeechRL, KrebsHA. Control of the redox state of the nicotinamide-adenine dinucleotide couple in rat liver cytoplasm. Biochem J, 126:59–65. 1972.
222.
SunX, WuF, DattaR, KharbandaS, KufeD. Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem, 275:7470–7473. 2000.
223.
TellG, DamanteG, CaldwellD, KelleyMR. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?Antioxid Redox Signal, 7:367–384. 2005.
TellG, PinesA, ParonI, D'EliaA, BiscaA, KelleyMR, ManziniG, DamanteG. Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain. J Biol Chem, 277:14564–14574. 2002.
226.
TellG, ScaloniA, PellizzariL, FormisanoS, PucilloC, DamanteG. Redox potential controls the structure and DNA binding activity of the paired domain. J Biol Chem, 273:25062–25072. 1998.
227.
TellG, ZeccaA, PellizzariL, SpessottoP, ColombattiA, KelleyMR, DamanteG, PucilloC. An “environment to nucleus” signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation. Nucleic Acids Res, 28:1099–1105. 2000.
228.
tenHoeve J, de JesusIbarra-Sanchez M, FuY, ZhuW, TremblayM, DavidM, ShuaiK. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol, 22:5662–5668. 2002.
229.
TienrungrojW, MeshinchiS, SanchezER, PrattSE, GrippoJF, HolmgrenA, PrattWB. The role of sulfhydryl groups in permitting transformation and DNA binding of the glucocorticoid receptor. J Biol Chem, 262:6992–7000. 1987.
230.
ToledanoMB, LeonardWJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A, 88:4328–4332. 1991.
231.
TonksNK. PTP1B: from the sidelines to the front lines!FEBS Lett, 546:140–148. 2003.
232.
TsujitaY, MuraskiJ, ShiraishiI, KatoT, KajsturaJ, AnversaP, SussmanMA. Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A, 103:11946–11951. 2006.
233.
ValkoM, RhodesCJ, MoncolJ, IzakovicM, MazurM. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 160:1–40. 2006.
234.
VeechRL, EgglestonLV, KrebsHA. The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem J, 115:609–619. 1969.
235.
VelichkovaM, HassonT. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol Cell Biol, 25:4501–4513. 2005.
236.
WahllanderA, SobollS, SiesH, LinkeI, MullerM. Hepatic mitochondrial and cytosolic glutathione content and the subcellular distribution of GSH-S-transferases. FEBS Lett, 97:138–140. 1979.
237.
WakabayashiN, Dinkova-KostovaAT, HoltzclawWD, KangMI, KobayashiA, YamamotoM, KenslerTW, TalalayP. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci U S A, 101:2040–2045. 2004.
238.
WakasugiN, TagayaY, WakasugiH, MitsuiA, MaedaM, YodoiJ, TurszT. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A, 87:8282–8286. 1990.
239.
WalkerDR, BondJP, TaroneRE, HarrisCC, MakalowskiW, BoguskiMS, GreenblattMS. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene, 18:211–218. 1999.
WangJ, PanS, BerkBC. Glutaredoxin mediates Akt and eNOS activation by flow in a glutathione reductase-dependent manner. Arterioscler Thromb Vasc Biol, 27:1283–1288. 2007.
242.
WangJ, TekleE, OubrahimH, MieyalJJ, StadtmanER, ChockPB. Stable and controllable RNA interference: investigating the physiological function of glutathionylated actin. Proc Natl Acad Sci U S A, 100:5103–5106. 2003.
243.
WangX, MartindaleJL, LiuY, HolbrookNJ. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J, 333:291–300. 1998.
244.
WeiSJ, BoteroA, HirotaK, BradburyCM, MarkovinaS, LaszloA, SpitzDR, GoswamiPC, YodoiJ, GiusD. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res, 60:6688–6695. 2000.
245.
WeinbergRL, VeprintsevDB, FershtAR. Cooperative binding of tetrameric p53 to DNA. J Mol Biol, 341:1145–1159. 2004.
246.
WengerRH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J, 16:1151–1162. 2002.
247.
WengerRH, StiehlDP, CamenischG. Integration of oxygen signaling at the consensus HRE. Sci STKE, 2005:re12. 2005.
248.
WilsonDM3rd, BarskyD. The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat Res, 485:283–307. 2001.
WitteS, VillalbaM, BiK, LiuY, IsakovN, AltmanA. Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kappaB pathways by PICOT, a novel protein kinase C-interacting protein with a thioredoxin homology domain. J Biol Chem, 275:1902–1909. 2000.
251.
WoodZA, SchroderE, RobinHarris J, PooleLB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci, 28:32–40. 2003.
252.
WuY, MoserM, BautchVL, PattersonC. HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells. Mol Cell Biol, 23:5680–5691. 2003.
253.
XanthoudakisS, CurranT. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J, 11:653–665. 1992.
254.
XanthoudakisS, MiaoG, WangF, PanYC, CurranT. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J, 11:3323–3335. 1992.
255.
XanthoudakisS, MiaoGG, CurranT. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc Natl Acad Sci U S A, 91:23–27. 1994.
256.
YamaguchiT, MikiY, YoshidaK. Protein kinase C delta activates IkappaB-kinase alpha to induce the p53 tumor suppressor in response to oxidative stress. Cell Signal, 19:2088–2097. 2007.
257.
YamamotoT, SekineY, KashimaK, KubotaA, SatoN, AokiN, MatsudaT. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem Biophys Res Commun, 297:811–817. 2002.
258.
YamanakaH, MaehiraF, OshiroM, AsatoT, YanagawaY, TakeiH, NakashimaY. A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system. Biochem Biophys Res Commun, 271:796–800. 2000.
259.
YoshidaK. PKCdelta signaling: mechanisms of DNA damage response and apoptosis. Cell Signal, 19:892–901. 2007.
260.
YuanZM, UtsugisawaT, IshikoT, NakadaS, HuangY, KharbandaS, WeichselbaumR, KufeD. Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene, 16:1643–1648. 1998.
261.
ZhangQ, PistonDW, GoodmanRH. Regulation of corepressor function by nuclear NADH. Science, 295:1895–1897. 2002.
262.
ZhuH, FuW, MattsonMP. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J Neurochem, 75:117–124. 2000.
263.
ZipperLM, MulcahyRT. Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol Sci, 73:124–134. 2003.
